FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Department of Medicine 4 – Nephrology and Hypertension
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Overview
Publications
(1,127)
Research Grants
(51)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Plasma renin and aldosterone concentrations related to endovascular ultrasound renal denervation in the RADIANCE-HTN SOLO trial (2022)
Fisher ND, Kirtane AJ, Daemen J, Rader F, Lobo MD, Saxena M, Abraham J, et al.
Journal article
Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years (2022)
Ott C, Mahfoud F, Mancia G, Narkiewicz K, Ruilope LM, Fahy M, Schlaich MP, et al.
Journal article
Renal denervation Really an alternative to reducing blood pressure? (2022)
Striepe K, Schiffer M, Schmieder R
Journal article
Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers (2022)
Geßner A, Gemeinhardt A, Bosch A, Kannenkeril D, Staerk C, Mayr A, Fromm M, et al.
Journal article
Apolipoprotein A-IV concentrations and clinical outcomes in a large chronic kidney disease cohort: Results from the GCKD study (2022)
Schwaiger JP, Kollerits B, Steinbrenner I, Weissensteiner H, Schoenherr S, Forer L, Kotsis F, et al.
Journal article
NT-proBNP and stem cell factor plasma concentrations are independently associated with cardiovascular outcomes in end-stage renal disease hemodialysis patients. (2022)
Rossignol P, Duarte K, Bresso E, Åsberg A, Devignes MD, Eriksson N, Girerd N, et al.
Journal article
The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial (2022)
Kolwelter J, Kannenkeril D, Linz P, Jung S, Nagel AM, Bosch A, Ott C, et al.
Journal article
Long-term reduction in morning and nighttime blood pressure after renal denervation: 36-month results from SPYRAL HTN-ON MED trial (2022)
Kario K, Mahfoud F, Kandzari DE, Townsend RR, Weber MA, Schmieder R, Tsioufis K, et al.
Journal article
Correction to: Two adjacent phosphorylation sites in the C-terminus of the channel's α-subunit have opposing effects on epithelial sodium channel (ENaC) activity. (2022)
Diakov A, Nesterov V, Dahlmann A, Korbmacher C
Journal article, Erratum
Midkine Promotes Metastasis and Therapeutic Resistance via mTOR/RPS6 in Uveal Melanoma. (2022)
Karg M, John L, Refaian N, Büttner C, Rottmar T, Sommer J, Bock B, et al.
Journal article
‹
1
...
22
23
24
25
26
...
113
›